Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples